Education
About Us
Working with TipRanks
Follow Us
Fresenius Medical Care (FMS)
NYSE:FMS
Total Valuation
Fresenius Medical Care has a market cap or net worth of $13.53B. The enterprise value is $20.78B.
Market Cap$13.53B
Enterprise Value$20.78B
Share Statistics
Fresenius Medical Care has 586,826,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding586,826,900
Owned by Insiders―
Owned by Institutions4.58%
Financial Efficiency
Fresenius Medical Care’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 5.34%.
Return on Equity (ROE)0.07
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)5.34%
Return on Capital Employed (ROCE)0.07
Revenue Per Employee175.20K
Profits Per Employee8.73K
Employee Count112,035
Asset Turnover0.63
Inventory Turnover6.82
Valuation Ratios
The current PE Ratio of Fresenius Medical Care is 12.4. Fresenius Medical Care’s PEG ratio is 0.14.
PE Ratio12.4
PS Ratio0.60
PB Ratio0.83
Price to Fair Value0.83
Price to FCF6.96
Price to Operating Cash Flow4.34
PEG Ratio0.14
Income Statement
In the last 12 months, Fresenius Medical Care had revenue of 19.63B and earned 978.00M in profits. Earnings per share was 1.68.
Revenue19.63B
Gross Profit5.03B
Operating Income1.83B
Pretax Income1.51B
Net Income978.00M
EBITDA2.96B
Earnings Per Share (EPS)1.68
Cash Flow
In the last 12 months, operating cash flow was 2.65B and capital expenditures -902.78M, giving a free cash flow of 1.75B billion.
Operating Cash Flow2.65B
Free Cash Flow1.75B
Free Cash Flow per Share2.98
Dividends & Yields
Fresenius Medical Care pays an annual dividend of $0.787, resulting in a dividend yield of 3.29%
Dividend Per Share$0.787
Dividend Yield3.29%
Payout Ratio37.27%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.50
52-Week Price Change4.73%
50-Day Moving Average23.29
200-Day Moving Average25.35
Relative Strength Index (RSI)49.53
Average Volume (3m)628.00K
Important Dates
Fresenius Medical Care upcoming earnings date is May 5, 2026, TBA (Confirmed).
Last Earnings DateFeb 24, 2026
Next Earnings DateMay 5, 2026
Ex-Dividend Date―
Financial Position
Fresenius Medical Care as a current ratio of 1.26, with Debt / Equity ratio of 75.58%
Current Ratio1.26
Quick Ratio0.92
Debt to Market Cap0.62
Net Debt to EBITDA3.11
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Fresenius Medical Care has paid 321.00M in taxes.
Income Tax321.00M
Effective Tax Rate0.21
Enterprise Valuation
Fresenius Medical Care EV to EBITDA ratio is 7.10, with an EV/FCF ratio of 12.38.
EV to Sales1.07
EV to EBITDA7.10
EV to Free Cash Flow12.38
EV to Operating Cash Flow8.16
Balance Sheet
Fresenius Medical Care has $1.60B in cash and marketable securities with $10.79B in debt, giving a net cash position of -$9.20B billion.
Cash & Marketable Securities$1.60B
Total Debt$10.79B
Net Cash-$9.20B
Net Cash Per Share-$15.67
Tangible Book Value Per Share-$0.93
Margins
Gross margin is 25.62%, with operating margin of 9.31%, and net profit margin of 4.98%.
Gross Margin25.62%
Operating Margin9.31%
Pretax Margin7.70%
Net Profit Margin4.98%
EBITDA Margin15.06%
EBIT Margin7.70%
Analyst Forecast
The average price target for Fresenius Medical Care is $26.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$26.00
Price Target Upside10.78% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast4.09%
EPS Growth Forecast13.17%